(Q42954961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Kazal Boron Biswas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A H M Nurun Nabi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yoshie Arai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tsutomu Nakagawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Atsuhiro Ichihara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Toshifumi Watanabe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tadashi Inagami

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Fumiaki Suzuki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

22 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Hypertension Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1053-1059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20664543%20AND%20SRC:MED&resulttype=core&format=json

Tertatolol in chronic renal failure. A pharmacokinetic study

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Activated prorenin as a therapeutic target for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Structure-based design of aliskiren, a novel orally effective renin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Prorenin has high affinity multiple binding sites for (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Efficient production of recombinant human (pro)renin utilizing a decahistidine tag attached at the C-terminus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Species specificity of prorenin binding to the (pro)renin receptor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Improvement of renin determination in human plasma using a commonly available renin standard in a radioimmunological method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Searching out low renin patients: limitations of some commonly used methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Biochemical properties of renin and prorenin binding to the (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Aliskiren accumulates in Renin secretory granules and binds plasma prorenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

Cellular biology of the renin-angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Renin: endocrine, paracrine, or part-paracrine control of blood pressure?

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Extrarenal renin and blood pressure regulation. An alternative viewpoint

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Human prorenin has "gate and handle" regions for its non-proteolytic activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

High plasma prorenin in diabetes mellitus and its correlation with some complications

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021

Identification of the active site of human renin with use of new fluorogenic peptides

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.136

7 January 2021